Biologics for eosinophilic oesophagitis: a systematic review ...
Abstract Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred …
Current state of biologics in treating eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated. This …
Biologics in eosinophilic esophagitis - PubMed
Biologics for treatment of EoE may result in symptom and histologic improvement and has the potential to treat disease with minimal side effects.
Biologics in the Treatment of Eosinophilic Esophagitis: Ready ...
Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including dysphagia and food …
DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb …